asbestos lawyers - Worthington & Caron, PC

Over $2.5 billion

obtained for mesothelioma patients & families

Hot Topics

News Posts in August, 2013

Aug 30 2013

New Immunotherapy Compound Anti-CD40 Slows Mesothelioma Tumor Growth After Recurrence

In the September 2013 issue of The Journal of Immunotherapy, researchers from the Western University of Australia published results of a study using a promising new immunotherapy compound and its effects on reoccurring mesothelioma tumors in lab ...

Continue Reading...
Aug 23 2013

Wall Street Journal Continues to Side with Asbestos Companies on Allegations of Asbestos Trust Fraud

The Wall Street Journal is continuing its practice of spreading asbestos trust fraud propaganda in its recent piece, “ Exposing Asbestos Fraud.” The piece alleges that the judiciary is standing in the way of justice and that a judge ...

Continue Reading...
Aug 16 2013

Drugs Used to Lower Cholesterol May Prove To Be Viable Mesothelioma Treatment Option

Researchers at Chiba University in Japan recently examined the response of mesothelioma cells when treated with a combination of two statin drugs commonly used to lower cholesterol and paired with a form of vitamin E called gamma tocotrienol (y-T3). ...

Continue Reading...
Aug 9 2013

The Chemical Safety Improvement Act of 2013 - Yet Another Obstacle to Banning Asbestos in the U.S

The Chemical Safety Improvement Act of 2013 (S. 1009) (CSIA) is a bill currently before congress. The legislation is designed to reform the Toxic Substances Control Act (TSCA) of 1976. Many public health advocates who support TSCA reform do not ...

Continue Reading...
Aug 1 2013

Australian Asbestos Diseases Research Institute Announces Clinical Trial for New Mesothelioma Drug

The Australian Asbestos Diseases Research Institute (ADRI) has announced a clinical trial for a newly developed drug therapy in the treatment of mesothelioma. Researchers at the ADRI conducted a three year study focused on the genetic characteristics ...

Continue Reading...

Get Empowered

We put your medical and personal needs first and provide compassionate representation.

Please enter the captcha above: